The professor believes that the explosive increase in the incidence will continue for another two weeks.
In an interview with Echo Moskvy radio station , virologist, doctor of biological sciences, professor at the School of Systems Biology at George Mason University Ancha Baranova told how long the summer increase in incidence in Russia will last and gave a personal rating of the effectiveness of vaccines existing in the world aimed at preventing covid.
What will happen to the coronavirus in Russia this summer?
A fairly strong rise in the incidence will be within the next 2 weeks, the expert said. This will be followed by a plateau (stabilization of the situation), 3 to 4 weeks long, after which the incidence of coronavirus in Moscow and Russia as a whole will decline. According to Anchi Baranova’s forecasts, by the end of the summer the situation with the coronavirus “will be completely normal.”
- How long the rise and plateau will continue depends on the behavior of the population and the measures taken by the authorities. I hope that the measures will be smart and, accordingly, will lead to a decrease, says the virologist.
Why is mass vaccination in Russia going slowly?
- Get vaccinated. “I hope that people are now a little scared and will just run to get vaccinated,” said Professor Ancha Baranova. If the rise in vaccination is achieved in the next 1.5 months, then by August the situation with the coronavirus will stabilize.
- In 2020, doctors have found how to treat covid. These are drugs aimed at the patient’s own body – glucocorticosteroids and anticoagulants, their use in treatment should be continued.
- Restrictive measures should be applied taking into account the situation in a particular region.
- Wear masks indoors when crowded and ventilate rooms.
If you get revaccinated, then with what?
In people who were vaccinated in Russia with Sputnik V, the level of antibodies is now decreasing, and we are also faced with the question of the need for re-vaccination.
- “Sputnik V” is quite suitable for increasing the level of antibodies in those who have already received this drug before, Ancha Baranova is sure.